zintick
AEI AlsetCorporate actionBankruptcy, delistings and restatements

Alset Receives Nasdaq Bid Price Notice, Has Until April 26, 2027

The company plans a 1-for-5 reverse stock split, with timing to be announced in the immediate future.

By Zintick Team · Editor: Kratik Mehta
Published

General view of the construction of a new residential complex. Multi-storey buildings and high-rise cranes.
Photo: Pedal to the Stock/Shutterstock.com

Key terms

  • Nasdaq notice dated Oct. 28, 2026: bid price below $1.00 for 30 consecutive trading days
  • Compliance deadline: April 26, 2027, under Nasdaq Rule 5810(c)(3)(A)
  • Possible additional 180 days if eligible; otherwise delisting process
  • Company plans a 1-for-5 reverse stock split, timing to be announced

Alset Inc. (Nasdaq: AEI) said in an 8-K filed Friday, Oct. 30, 2026, that it received a notice from Nasdaq's Listing Qualifications Department on Oct. 28, 2026.

The notice says the company's closing bid price on The Nasdaq Capital Market was below $1.00 for 30 consecutive trading days. That falls short of the Minimum Bid Price Requirement under Nasdaq Marketplace Rule 5550(a)(2), which calls for $1.00 per share.

Compliance deadline

The notice has no immediate effect on the listing, so the common stock continues to trade on Nasdaq. Under Nasdaq Marketplace Rule 5810(c)(3)(A), the company has 180 calendar days from Oct. 28, 2026, or until April 26, 2027, to regain compliance. Compliance requires a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days before that date. Nasdaq would then confirm compliance in writing.

What the company plans

If the company does not regain compliance by April 26, 2027, it may be eligible for an additional 180 calendar days. To qualify, it would need to meet the market value of publicly held shares requirement and the other initial listing standards for the Capital Market, apart from the bid price, and give written notice of its intent to cure the deficiency, including by reverse stock split if necessary. If Nasdaq staff determines the company cannot cure the deficiency or is otherwise ineligible, its securities would be subject to delisting. The company could appeal that decision, but the filing says there is no assurance Nasdaq would grant continued listing.

Alset said it will keep monitoring its bid price through April 26, 2027, and will weigh options to resolve the shortfall. The company previously announced plans for a 1-for-5 reverse stock split and expects to announce its timing soon. The company's last close before the filing was $0.51 on Oct. 30, 2026, with a market value of about $19.8 million based on 38.9 million shares as of Aug. 14, 2026.

Sources

Written with AI from the company's SEC filing and our market data, and checked against those sources before publishing. Our editorial standards.

AEI page →

Filings, figures and price history are on the Alset page.